| [1] |
Vere J, Gibson B. Evidence-based medicine as science[J]. J Eval Clin Pract, 2019, 25(6): 997-1002.
|
| [2] |
Ammenwerth E. Evidence-based Health informatics: how do we know what we know?[J]. Methods Inf Med, 2015, 54(4): 298-307.
|
| [3] |
Hager A, Lindblad S, Brommels M, et al. Sharing patient-controlled real-world data through the application of the theory of commons: action research case study[J]. J Med Internet Res, 2021, 23(1): e16842.
|
| [4] |
HerniaSurge Group. International guidelines for groin hernia management.[J]. Hernia, 2018, 22(1): 1-165.
|
| [5] |
Kyle-Leinhase I, Köckerling F, Jørgensen LN, et al. Comparison of hernia registries: the CORE project[J]. Hernia, 2018, 22(4): 561-575.
|
| [6] |
Gouws J, Nel D, Bougard HC, et al. Building a national hernia registry in South Africa: initial ventral hernia repair results from a diverse healthcare sector[J]. Hernia, 2020.
|
| [7] |
Stechemesser B, Jacob DA, Schug-Paβ C, et al. Herniamed: an internet-based registry for outcome research in hernia surgery[J]. Hernia, 2012, 16(3): 269-276.
|
| [8] |
秦昌富，申英末，李炳根, 等. 中国疝病注册登记随访系统发展现状及数据初步分析[J]. 中华消化外科杂志, 2018, 17(11): 1087-1089.
|
| [9] |
Köckerling F, Maneck M, Günster C, et al. Comparing routine administrative data with registry data for assessing quality of hospital care in patients with inguinal hernia[J]. Hernia, 2020, 24(1): 143-151.
|
| [10] |
Helgstrand F, Thygesen LC, Bisgaard T, et al. Differential recurrence after laparoscopic incisional hernia repair: importance of a nationwide registry-based mesh surveillance[J]. Br J Surg, 2020, 107(9): 1130-1136.
|
| [11] |
Baumfeld Andre E, Reynolds R, Caubel P, et al. Trial designs using real-world data: the changing landscape of the regulatory approval process.[J]. Pharmacoepidemiol Drug Saf, 2020, 29(10): 1201-1212.
|
| [12] |
Breckenridge AM, Breckenridge RA, Peck CC. Report on the current status of the use of real-world data(RWD) and real-world evidence(RWE) in drug development and regulation[J]. Br J Clin Pharmacol, 2019, 85(9): 1874-1877.
|
| [13] |
Snyder JM, Pawloski JA, Poisson LM. Developing real-world evidence-ready datasets: time for clinician engagement[J]. Curr Oncol Rep, 2020, 22(5): 45.
|
| [14] |
Makady A, de Boer A, Hillege H, et al. What is real-world data? a review of definitions based on literature and stakeholder interviews[J]. Value Health, 2017, 207(7): 858-865.
|
| [15] |
Jin F, Yao C, Yan X, et al. Gap between real-world data and clinical research within hospitals in China: a qualitative study[J]. BMJ Open, 2020, 10(12): e038375.
|
| [16] |
Lavigne JE, Lagerberg T, Ambrosi JW, et al. Study designs and statistical approaches to suicide and prevention research in real-world data[J]. Suicide Life Threat Behav, 2021 Feb;51(1): 127-136.
|
| [17] |
Fang Y, He W, Wang H, et al. Key considerations in the design of real-world studies[J]. Contemp Clin Trials, 2020, 96: 106091.
|
| [18] |
Basu A, Axelsen K, Grabowski DC, et al. Real-world data: policy issues regarding their access and use[J]. Med Care, 2016, 54(12): 1038-1044.
|
| [19] |
李春晓，陈玉欢，凌霄, 等. 基于真实世界大数据的中药注射剂比较效益研究方法的思考[J]. 中医杂志, 2020, 61(14): 1234-1237, 1241.
|
| [20] |
吴丽娜，谢雁鸣，刘峘, 等. 结肠恶性肿瘤证候分布及用药特点的真实世界研究[J]. 中国中药杂志, 2020, 45(5): 1174-1179.
|
| [21] |
Köckerling F, Lorenz R, Hukauf M, et al. Influencing factors on the outcome in female groin hernia repair: a registry-based multivariable analysis of 15601 patients[J]. Ann Surg, 2019, 270(1): 1-9.
|
| [22] |
童松贵，杨洁. 腹股沟嵌顿斜疝发生的危险因素及不同手术方式的治疗效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(4): 424-427.
|
| [23] |
李征威，张玉新，王磊, 等. 成人腹股沟嵌顿疝发生肠坏死的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(4): 433-437.
|
| [24] |
Perez AJ, Strassle PD, Sadava EE, et al. Nationwide analysis of inpatient laparoscopic versus open inguinal hernia repair[J]. J Laparoendosc Adv Surg Tech A, 2020, 30(3): 292-298.
|
| [25] |
RanaG, Armijo PR, Khan S, et al. Outcomes and impact of laparoscopic inguinal hernia repair versus open inguinal hernia repair on healthcare spending and employee absenteeism[J]. Surg Endosc, 2020, 34(2): 821-828.
|
| [26] |
Bullen NL, Massey LH, Antoniou SA, et al. Open versus laparoscopic mesh repair of primary unilateral uncomplicated inguinal hernia: a systematic review with meta-analysis and trial sequential analysis[J]. Hernia, 2019, 23(3): 461-472.
|
| [27] |
Ramjist JK, Dossa F, Stukel TA, et al. Reoperation for inguinal hernia recurrence in Ontario: a population-based study[J]. Hernia, 2019, 23(4): 647-654.
|
| [28] |
Merola G, Cavallaro G, Iorio O, et al. Learning curve in open inguinal hernia repair: a quality improvement multicentre study about Lichtenstein technique[J]. Hernia, 2020, 24(3): 651-659.
|
| [29] |
Shibuya S, Fujiwara N, Ochi T, et al. The learning curve of laparoscopic percutaneous extraperitoneal closure(LPEC) for inguinal hernia: protocoled training in a single center for six pediatric surgical trainees[J]. BMC Surg, 2019, 19(1): 6.
|
| [30] |
Köckerling F, Hoffmann H, Mayer F, et al. What are the trends in incisional hernia repair? Real-world data over 10 years from the Herniamedregistry[J]. Hernia, 2020.
|
| [31] |
Omar YK, Naseem Bou-Ayash, Fahri Gokcal. Robotic transabdominalpreperitoneal repair of complex inguinal hernias[J]. Inter J Abdominal Wall Hernia Surg, 2021, 4(1): 1-6.
|
| [32] |
Carbonell AM, Warren JA, Prabhu AS, et al. Reducing length of stay using a robotic-assisted approach for retromuscular ventral hernia repair: a comparative analysis from the americas hernia society quality collaborative[J]. Ann Surg, 2018, 267(2): 210-217.
|
| [33] |
LaPinska M, Kleppe K, Webb L, et al. Robotic-assisted and laparoscopic hernia repair: real-world evidence from the Americas Hernia Society Quality Collaborative(AHSQC)[J]. Surg Endosc, 2021, 353(3): 1331-1341.
|
| [34] |
Rognoni C, Cuccurullo D, Borsoi L, et al. Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the "Italian Hernia Club" registry[J]. Sci Rep, 2020, 10(1): 10706.
|
| [35] |
Köckerling F, Simon T, Hukauf M, et al. The Importance of Registries in the Postmarketing Surveillance of Surgical Meshes[J]. Ann Surg, 2018, 268(6): 1097-1104.
|
| [36] |
Orsini LS, Berger M, Crown W, et al. Improving Transparency to build trust in real-world secondary data studies for hypothesis testing-why, what, and how: recommendations and a road map from the real-world evidence transparency initiative[J]. Value Health, 2020, 23(9): 1128-1136.
|
| [37] |
WedamS, Fashoyin-Aje L, Bloomquist E, et al. FDA Approval summary: palbociclib for male patients with metastatic breast cancer[J]. Clin Cancer Res, 2020, 26(6): 1208-1212.
|
| [38] |
Wu J, Wang C, Toh S, et al. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions[J]. Pharmacoepidemiol Drug Saf, 2020, 29(10): 1213-1218.
|
| [39] |
Schizas D, Apostolou K, Hasemaki N, et al. Obturator hernias: a systematic review of the literature[J]. Hernia, 2020, 251(1): 193-204.
|
| [40] |
Sartori A, De Luca M, Noaro G, et al. Rare Intraoperative and postoperative complications after transabdominal laparoscopic hernia repair: results from the multicenter wall hernia group registry[J]. J Laparoendosc Adv Surg Tech A, 2021, 313(3): 290-295.
|
| [41] |
Ecker BL, Kuo LE, Simmons KD, et al. Laparoscopic versus open ventral hernia repair: longitudinal outcomes and cost analysis using statewide claims data[J]. Surg Endosc, 2016, 30(3): 906-915.
|